80_FR_51975 80 FR 51810 - Federal Management Regulations; Improved Management of Undeliverable-as-Addressed Mail

80 FR 51810 - Federal Management Regulations; Improved Management of Undeliverable-as-Addressed Mail

GENERAL SERVICES ADMINISTRATION

Federal Register Volume 80, Issue 165 (August 26, 2015)

Page Range51810-51810
FR Document2015-21187

The General Services Administration has issued Federal Management Regulation (FMR) Bulletin G-05, which provides guidance to Executive Branch agencies for improving management of undeliverable-as- addressed (UAA) mail. The bulletin provides agencies with information on the tools and best practices associated with UAA mail. The FMR Bulletin G-05 and all other FMR bulletins are located at http:// www.gsa.gov/fmrbulletins.

Federal Register, Volume 80 Issue 165 (Wednesday, August 26, 2015)
[Federal Register Volume 80, Number 165 (Wednesday, August 26, 2015)]
[Notices]
[Page 51810]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-21187]


=======================================================================
-----------------------------------------------------------------------

GENERAL SERVICES ADMINISTRATION

[Notice-MA-2015-04; Docket No. 2015-0002; Sequence 22]


Federal Management Regulations; Improved Management of 
Undeliverable-as-Addressed Mail

AGENCY: Office of Government-Wide Policy, General Services 
Administration (GSA).

ACTION: Notice of a bulletin.

-----------------------------------------------------------------------

SUMMARY: The General Services Administration has issued Federal 
Management Regulation (FMR) Bulletin G-05, which provides guidance to 
Executive Branch agencies for improving management of undeliverable-as-
addressed (UAA) mail. The bulletin provides agencies with information 
on the tools and best practices associated with UAA mail. The FMR 
Bulletin G-05 and all other FMR bulletins are located at http://www.gsa.gov/fmrbulletins.

DATES: Effective Date: August 26, 2015.

FOR FURTHER INFORMATION CONTACT: Ms. Cynthia Patterson, Office of 
Government-wide Policy (MAF), Office of Asset and Transportation 
Management, General Services Administration, at 703-589-2641 or via 
email at [email protected]. Please cite FMR Bulletin G-05.

SUPPLEMENTARY INFORMATION: FMR Bulletin G-05 consolidates information 
regarding tools and best practices for management of UAA mail from a 
number of sources. Better management of UAA mail reduces mailing costs 
and associated personnel costs, improves community outreach and 
relations, supports sustainability efforts by reducing printing, paper 
use, and energy consumption, and is consistent with the goals of 
Executive Orders 13589 and 13693, and the Federal Management 
Regulation. The four suggestions described in this bulletin are: (1) 
Establish internal policies to obtain and verify address correction, 
(2) prior to mailing, use USPS[supreg] certified vendors' address 
management tools, (3) actively manage returned mail with barcodes and 
scanning technology, and (4) track, monitor, and report returned mail 
on an annual basis to help the Federal community avoid UAA mail.

    Dated: August 7, 2015.
Christine Harada,
Associate Administrator, Office of Government-wide Policy, General 
Services Administration.
[FR Doc. 2015-21187 Filed 8-25-15; 8:45 am]
BILLING CODE 6820-14-P



                                               51810                      Federal Register / Vol. 80, No. 165 / Wednesday, August 26, 2015 / Notices

                                               version of a drug product for which Par                    The proposed orders each include a                    GENERAL SERVICES
                                               is seeking FDA approval to sell a generic               notice provision designed to assist in                   ADMINISTRATION
                                               counterpart; and (2) the limitation                     monitoring the respondents’ future
                                               extends beyond the expiration of any                    conduct with respect to an agreement to                  [Notice–MA–2015–04; Docket No. 2015–
                                               Orange-Book listed patents for the drug                 restrict the sale of an authorized generic               0002; Sequence 22]
                                               in question.6                                           product—without regard to whether the
                                                  In the Concordia order, Paragraph II                                                                          Federal Management Regulations;
                                                                                                       agreement extends beyond expiration of                   Improved Management of
                                               requires Concordia to relinquish any                    any listed patent. Par is required to
                                               and all rights to payment under the                                                                              Undeliverable-as-Addressed Mail
                                                                                                       notify the Commission and provide
                                               License Agreement and to provide                                                                                 AGENCY:  Office of Government-Wide
                                                                                                       certain specified information if it enters
                                               written notice to Par and the FTC of that                                                                        Policy, General Services Administration
                                               relinquishment. Paragraph III bars                      certain agreements with a party that
                                                                                                       markets a brand-name drug for which                      (GSA).
                                               Concordia from entering any agreement
                                                                                                       Par has filed an application to sell a                   ACTION: Notice of a bulletin.
                                               with a generic applicant for a reference-
                                               listed drug for which Concordia holds                   generic equivalent. Covered agreements
                                                                                                                                                                SUMMARY:   The General Services
                                               the NDA, if the agreement (1) limits                    are those that (1) limit the sale of an
                                                                                                                                                                Administration has issued Federal
                                               marketing of an authorized generic                      authorized generic and (2) take effect
                                                                                                                                                                Management Regulation (FMR) Bulletin
                                               version of that drug and (2) the                        before the expiration of all Orange-Book
                                                                                                                                                                G–05, which provides guidance to
                                               limitation extends beyond the                           listed patents for the relevant brand-                   Executive Branch agencies for
                                               expiration of any Orange-Book listed                    name drug. A comparable provision in                     improving management of
                                               patents for the drug in question.                       the Concordia order requires Concordia                   undeliverable-as-addressed (UAA) mail.
                                                  The proposed orders’ prohibitions on                 to provide such notice for agreements                    The bulletin provides agencies with
                                               future agreements limiting an                           with a party seeking FDA approval to                     information on the tools and best
                                               authorized generic cover only                           market a generic version of a brand-                     practices associated with UAA mail.
                                               agreements in which the restraint                       name drug for which Concordia holds                      The FMR Bulletin G–05 and all other
                                               extends beyond patent expiration.                       the NDA. Both notice provisions                          FMR bulletins are located at http://
                                               Agreements to restrict the sale of an                   terminate ten years after issuance of the                www.gsa.gov/fmrbulletins.
                                               authorized generic sometimes appear in                  orders.                                                  DATES: Effective Date: August 26, 2015.
                                               patent litigation settlements and can
                                               serve as a means of compensating the                       These notice provisions differ from                   FOR FURTHER INFORMATION CONTACT: Ms.
                                               generic patent challenger for agreeing to               the filing requirements contained in                     Cynthia Patterson, Office of
                                               stay off the market for a period of time.7              Section 1112 of the Medicare                             Government-wide Policy (MAF), Office
                                               These arrangements can raise the same                   Prescription Drug, Improvement and                       of Asset and Transportation
                                               antitrust concerns that the Supreme                     Modernization Act of 2003 (MMA). The                     Management, General Services
                                               Court addressed in FTC v. Actavis, 133                  notice required by the orders must be                    Administration, at 703–589–2641 or via
                                               S. Ct. 2223 (2013).8 That is not this case,             filed at least 30 days prior to the                      email at cynthia.patterson@gsa.gov.
                                               however, and the proposed orders are                    effective date of the agreement; MMA                     Please cite FMR Bulletin G–05.
                                               not designed to address that type of                    filings must be made within ten days                     SUPPLEMENTARY INFORMATION: FMR
                                               conduct. As discussed above, the                        after execution of the agreement.                        Bulletin G–05 consolidates information
                                               challenged agreement here did not arise                    The proposed orders also require that                 regarding tools and best practices for
                                               out of pending or threatened patent                     for five years Par and Concordia                         management of UAA mail from a
                                               litigation and nearly the entire five-year                                                                       number of sources. Better management
                                                                                                       maintain compliance programs with
                                               term of the agreement covered the                                                                                of UAA mail reduces mailing costs and
                                                                                                       certain prescribed features. Finally, the
                                               period after expiration of the Kapvay                                                                            associated personnel costs, improves
                                                                                                       proposed orders contain certain
                                               patent.                                                                                                          community outreach and relations,
                                                  For purposes of these proposed                       reporting and other provisions that are                  supports sustainability efforts by
                                               orders, ‘‘authorized generic’’ means a                  designed to assist the Commission in                     reducing printing, paper use, and energy
                                               drug product distributed by or on behalf                monitoring compliance and are standard                   consumption, and is consistent with the
                                               of an NDA holder, but marketed as a                     provisions in Commission orders. The                     goals of Executive Orders 13589 and
                                               generic, regardless of whether it is                    proposed orders will expire in 20 years.                 13693, and the Federal Management
                                               manufactured pursuant to an NDA, an                       By direction of the Commission.                        Regulation. The four suggestions
                                               ANDA, or a 505(b)(2) application.9                      Donald S. Clark,                                         described in this bulletin are: (1)
                                                                                                       Secretary.
                                                                                                                                                                Establish internal policies to obtain and
                                                 6 This provision applies to actions taken on behalf
                                                                                                                                                                verify address correction, (2) prior to
                                               of Par Pharmaceutical, Inc., and Par Pharmaceutical     [FR Doc. 2015–21071 Filed 8–25–15; 8:45 am]
                                               Holdings, Inc., but would not apply to conduct by
                                                                                                                                                                mailing, use USPS® certified vendors’
                                                                                                       BILLING CODE 6750–01–P                                   address management tools, (3) actively
                                               Respondent TPG Partners VI, L.P. that is not taken
                                               on behalf of the Par entities.                                                                                   manage returned mail with barcodes
                                                 7 See, e.g., Authorized Generic Study at 139–53.
                                                                                                                                                                and scanning technology, and (4) track,
                                                 8 See King Drug Co. of Florence Inc.v. Smithkline
                                                                                                                                                                monitor, and report returned mail on an
                                               Beecham Corp., No. 14–1243 (3rd Cir. June 26,
                                               2015). See also Brief of Federal Trade Commission
                                                                                                                                                                annual basis to help the Federal
                                               as Amicus Curiae, American Sales Co.v. Warner-                                                                   community avoid UAA mail.
rmajette on DSK7SPTVN1PROD with NOTICES




                                               Chilcott Co., LLC, Nos. 14–2071 and 15–1250 (1st                                                                   Dated: August 7, 2015.
                                               Cir. June 16, 2015).
                                                 9 A company seeking to market a generic product                                                                Christine Harada,
                                               typically files an abbreviated new drug application                                                              Associate Administrator, Office of
                                               (ANDA). In that case, instead of providing                                                                       Government-wide Policy, General Services
                                               independent evidence of safety and effectiveness,       need to submit reports of investigations of the safety
                                                                                                                                                                Administration.
                                               the applicant must demonstrate that its drug is         and effectiveness of its product in addition to
                                               bioequivalent to its branded counterpart. In some       relying on existing data, under what is known as         [FR Doc. 2015–21187 Filed 8–25–15; 8:45 am]
                                               circumstances, a generic drug manufacturer may          a ‘‘505(b)(2)’’ application.                             BILLING CODE 6820–14–P




                                          VerDate Sep<11>2014   14:29 Aug 25, 2015   Jkt 235001   PO 00000   Frm 00046   Fmt 4703   Sfmt 9990   E:\FR\FM\26AUN1.SGM    26AUN1



Document Created: 2015-12-15 10:58:23
Document Modified: 2015-12-15 10:58:23
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of a bulletin.
ContactMs. Cynthia Patterson, Office of Government-wide Policy (MAF), Office of Asset and Transportation Management, General Services Administration, at 703-589-2641 or via email at [email protected] Please cite FMR Bulletin G-05.
FR Citation80 FR 51810 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR